Tecan Group AG (VIE:TECN)

Market Cap	1.84B -40.3%
Revenue (ttm)	970.69M -9.3%
Net Income	67.59M -37.7%
EPS	5.30 -37.2%
Shares Out	n/a
PE Ratio	27.25
Forward PE	18.90
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	9
Open	152.80
Previous Close	151.90
Day's Range	152.80 - 152.80
52-Week Range	129.60 - 173.30
Beta	n/a
RSI	42.72
Earnings Date	Mar 16, 2026

About Tecan Group AG

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service; Synergence, a customized O...

• Industry: Commercial Physical and Biological Research
• Founded: 1980
• Employees: 3,000
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: TECN

Financial Performance

In 2024, Tecan Group AG's revenue was 934.28 million, a decrease of -13.04% compared to the previous year's 1.07 billion. Earnings were 67.66 million, a decrease of -48.77%.

Financial numbers in CHF